Month: November 2022

On December 31, 2020, Xu, Mengyu; Wang, Chun-Hung; Terracciano, Anthony C.; Masunov, Artem E.; Vasu, Subith S. published an article.SDS of cas: 39512-49-7 The title of the article was High accuracy machine learning identification of fentanyl-relevant molecular compound classification via constituent functional group analysis. And the article contained the following:

Fentanyl is an anesthetic with a high bioavailability and is the leading cause of drug overdose death in the U. S. Fentanyl and its derivatives have a low LD and street drugs which contain such compounds may lead to death of the user and simultaneously pose hazards for first responders. Rapid identification methods of both known and emerging opioid fentanyl substances is crucial. In this effort, machine learning (ML) is applied in a systematic manner to identify fentanyl-related functional groups in such compounds based on their observed spectral properties. In our study, accurate IR (IR) spectra of common organic mols. which contain functional groups that are constituents of fentanyl is determined by investigating the structure-property relationship. The average accuracy rate of correctly identifying the functional groups of interest is 92.5% on our testing data. All the IR spectra of 632 organic mols. are from National Institute of Standards and Technol. (NIST) database as the training set and are assessed. Results from this work will provide Artificial Intelligence (AI) based tools and algorithms increased confidence, which serves as a basis to detect fentanyl and its derivatives The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).SDS of cas: 39512-49-7

The Article related to fentanyl mol compound classification machine learning functional group analysis, Toxicology: Methods (Including Analysis) and other aspects.SDS of cas: 39512-49-7

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

On February 29, 2020, Daerr, Markus; Pabel, Joerg; Hoefner, Georg; Mayer, Peter; Wanner, Klaus T. published an article.Safety of 4-(4-Chlorophenyl)piperidin-4-ol The title of the article was Synthesis and biological evaluation of fluorescent GAT-ligands based on meso-substituted BODIPY dyes. And the article contained the following:

BODIPY dyes are known for their outstanding spectroscopic properties and are therefore established in a range of fluorescence based anal. techniques for in vitro as well as for in vivo measurements. For the first time, the authors designed and synthesized a series of fluorescent ligands for the SLC6 family transporters mGAT1-mGAT4 based on BODIPY dyes as fluorogenic subunits. In the novel series of fluorescent compounds, BODIPY dye subunits are linked with an alkyl chain of three to five carbon atoms that originates from the meso-position of the BODIPY dye to the amino function of different cyclic amines. Screening of these fluorescent probes for their biol. activity as GABA uptake inhibitors of mGAT1-mGAT4 revealed ligands with pIC50 values up to 5.35. The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).Safety of 4-(4-Chlorophenyl)piperidin-4-ol

The Article related to fluorescent gat ligand bodipy dye, Placeholder for records without volume info and other aspects.Safety of 4-(4-Chlorophenyl)piperidin-4-ol

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

On October 31, 2022, Karakaya, Guelsah; Tuere, Asli; Ozdemir, Aysun; Ozcelik, Berrin; Aytemir, Mutlu published an article.Related Products of 39512-49-7 The title of the article was Synthesis and molecular modeling of some novel hydroxypyrone derivatives as antidermatophytic agents. And the article contained the following:

Dermatophytes are pathogenic fungi, comprising the major cause of superficial fungal infections called dermatophytes. Although they infect keratinized tissues such as skin, nail, and hair, invasive serious infections may occur in immunocompromised patients. However, current antifungal drugs show considerable drawbacks, such as toxicity and multiple drug resistance, compelling and directing researches for new antidermatophyte agents. Herein, a series of hydroxypyrone bearing compounds inspired from the natural metabolite kojic acid was reported. Their antidermatophytic effects of the compounds against Microsporum gypseum, Trichophyton mentagrophytes var. erinaceid, and Epidermophyton floccosum were evaluated. The cytotoxicity of the compounds on healthy (MRC-5) and carcinogenic (He-La) cell lines was also investigated, and their cytopathogenic effects were expressed as maximum non-toxic concentrations According to the activity studies, compounds 10 and 22 were found as the most promising antidermatophytic agents (MIC: 2 μg/mL), exhibiting comparable effect with that of griseofulvin (MIC: 0.5-1 μg/mL) and terbinafine (MIC: 0.125-0.5 μg/mL) which are the most widely used agents for treating mycoses caused by dermatophytes. Mol. docking anal. of the most active compounds, compound 10 and compound 22, with homol. model of β-tubulin protein was carried out to investigate the possible binding conformation of the compounds in the targeted macromol. The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).Related Products of 39512-49-7

The Article related to microsporum trichophyton epidermophyton hydroxypyrone mol modeling antifungal, Placeholder for records without volume info and other aspects.Related Products of 39512-49-7

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

On February 9, 2017, Buckley, Dennis; Winter, Georg; Phillips, Andrew J.; Heffernan, Timothy; Bradner, James; Roberts, Justin; Nabet, Behnam published a patent.COA of Formula: C14H10N2O6 The title of the patent was Regulation of protein levels using ligand-binding domains for chemical regulation of proteolytic degradation. And the patent contained the following:

A method of modulating protein levels in vivo in a manner that avoids problems associated with CRISPR/Cas gene editing by making the protein susceptible to chem.-induced protein degradation is described. A sequence encoding a protein domain binding a heterobifunctional compound is inserted into the gene of interest, leading to synthesis of the fusion protein. One functional domain of the heterobifunctional compound binds to the fusion protein, and the other binds to a protein that recruits an E3 ubiquitin ligase leading to ubiquitination and degradation The use of FK506-binding proteins as the ligand-binding domains with heterobifunctional FK506 derivatives as the regulating mol. is demonstrated. The experimental process involved the reaction of 2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindoline-5-carboxylic acid(cas: 1216805-11-6).COA of Formula: C14H10N2O6

The Article related to proteolysis induction fusion protein heterobifunctional ligand ubiquitination, General Biochemistry: Subcellular Processes and other aspects.COA of Formula: C14H10N2O6

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

Punetha, Ankita; Green, Keith D.; Garzan, Atefeh; Thamban Chandrika, Nishad; Willby, Melisa J.; Pang, Allan H.; Hou, Caixia; Holbrook, Selina Y. L.; Krieger, Kyle; Posey, James E.; Parish, Tanya; Tsodikov, Oleg V.; Garneau-Tsodikova, Sylvie published an article in 2021, the title of the article was Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance.Application In Synthesis of 4-(4-Chlorophenyl)piperidin-4-ol And the article contains the following content:

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a deadly bacterial disease. Drug-resistant strains of Mtb make eradication of TB a daunting task. Overexpression of the enhanced intracellular survival (Eis) protein by Mtb confers resistance to the second-line antibiotic kanamycin (KAN). Eis is an acetyltransferase that acetylates KAN, inactivating its antimicrobial function. Development of Eis inhibitors as KAN adjuvant therapeutics is an attractive path to forestall and overcome KAN resistance. We discovered that an antipsychotic drug, haloperidol (HPD, 1), was a potent Eis inhibitor with IC50 = 0.39 ± 0.08 μM. We determined the crystal structure of the Eis-haloperidol (1) complex, which guided synthesis of 34 analogs. The structure-activity relationship study showed that in addition to haloperidol (1), eight analogs, some of which were smaller than 1, potently inhibited Eis (IC50 ≤ 1 μM). Crystal structures of Eis in complexes with three potent analogs and droperidol (DPD), an antiemetic and antipsychotic, were determined Three compounds partially restored KAN sensitivity of a KAN-resistant Mtb strain K204 overexpressing Eis. The Eis inhibitors generally did not exhibit cytotoxicity against mammalian cells. All tested compounds were modestly metabolically stable in human liver microsomes, exhibiting 30-60% metabolism over the course of the assay. While direct repurposing of haloperidol as an anti-TB agent is unlikely due to its neurotoxicity, this study reveals potential approaches to modifying this chem. scaffold to minimize toxicity and improve metabolic stability, while preserving potent Eis inhibition. The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).Application In Synthesis of 4-(4-Chlorophenyl)piperidin-4-ol

The Article related to mycobacterium tuberculosis kanamycin resistance haloperidol analog acetyltransferase eis inhibitor, Placeholder for records without volume info and other aspects.Application In Synthesis of 4-(4-Chlorophenyl)piperidin-4-ol

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

On February 28, 2022, Lier, Svenja; Sellmer, Andreas; Orben, Felix; Heinzlmeir, Stephanie; Krauss, Lukas; Schneeweis, Christian; Hassan, Zonera; Schneider, Carolin; Schaefer, Arlette; Pongratz, Herwig; Engleitner, Thomas; Oellinger, Rupert; Kuisl, Anna; Bassermann, Florian; Schlag, Christoph; Kong, Bo; Dove, Stefan; Kuster, Bernhard; Rad, Roland; Reichert, Maximilian; Wirth, Matthias; Saur, Dieter; Mahboobi, Siavosh; Schneider, Guenter published an article.SDS of cas: 1216805-11-6 The title of the article was A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer. And the article contained the following:

Targeted protein degradation offers new opportunities to inactivate cancer drivers and has successfully entered the clinic. Ways to induce selective protein degradation include proteolysis targeting chimera (PROTAC) technol. and immunomodulatory (IMiDs) / next-generation Cereblon (CRBN) E3 ligase modulating drugs (CELMoDs). Here, we aimed to develop a MYC PROTAC based on the MYC-MAX dimerization inhibitor 10058-F4 derivative 28RH and Thalidomide, called MDEG-541. We show that a subgroup of gastrointestinal cancer cell lines and primary patient-derived organoids are MDEG-541 sensitive. Although MYC expression was regulated in a CRBN-, proteasome- and ubiquitin-dependent manner, we provide evidence that MDEG-541 induced the degradation of CRBN neosubstrates, including G1 to S phase transition 1/2 (GSPT1/2) and the Polo-like kinase 1 (PLK1). In sum, we have established a CRBN-dependent degrader of relevant cancer targets with activity in gastrointestinal cancers. The experimental process involved the reaction of 2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindoline-5-carboxylic acid(cas: 1216805-11-6).SDS of cas: 1216805-11-6

The Article related to gastrointestinal cancer plk1 cereblon e3 ligase modulator antitumor, cereblon, gspt1, gspt2, myc, plk1, Placeholder for records without volume info and other aspects.SDS of cas: 1216805-11-6

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

On February 15, 2022, Dichiara, Maria; Artacho-Cordon, Antonia; Turnaturi, Rita; Santos-Caballero, Miriam; Gonzalez-Cano, Rafael; Pasquinucci, Lorella; Barbaraci, Carla; Rodriguez-Gomez, Isabel; Gomez-Guzman, Manuel; Marrazzo, Agostino; Cobos, Enrique J.; Amata, Emanuele published an article.Category: piperidines The title of the article was Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation. And the article contained the following:

The development of σ1 receptor antagonists hybridized with a H2S-donor is here reported. We aimed to obtain improved analgesic effects when compared to σ1 receptor antagonists or H2S-donors alone. In an in vivo model of sensory hypersensitivity, thioamide 1a induced analgesia which was synergistically enhanced when associated with the σ1 receptor antagonist BD-1063. The selective σ1 receptor agonist PRE-084 completely reversed this effect. Four thioamide H2S-σ1 receptor hybrids (5a-8a) and their amide derivatives (5b-8b) were synthesized. Compound 7a (AD164) robustly released H2S and showed selectivity for σ1 receptor over σ2 and opioid receptors. This compound induced marked analgesia that was reversed by PRE-084. The amide analog 7b (AD163) showed only minimal analgesia. Further studies showed that 7a exhibited negligible acute toxicity, together with a favorable pharmacokinetic profile. To the best of our knowledge, compound 7a is the first dual-acting ligand with simultaneous H2S-release and σ1 antagonistic activities. The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).Category: piperidines

The Article related to pain analgesic effect pharmacokinetics antagonism, analgesia, antagonist, dual ligands, hydrogen sulfide donor, sigma-1 receptor, Placeholder for records without volume info and other aspects.Category: piperidines

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

On April 30, 2022, Zhu, Zhenjun; Huang, Rui; Liu, Wei; Wang, Juan; Wu, Shujian; Chen, Mengfei; Huang, Aohuan; Xie, Yizhen; Chen, Moutong; Jiao, Chunwei; Zhang, Jumei; Wu, Qingping; Ding, Yu published an article.Reference of 4-(4-Chlorophenyl)piperidin-4-ol The title of the article was Whole Agrocybe cylindracea Prevented Obesity Linking with Modification of Gut Microbiota and Associated Fecal Metabolites in High-Fat Diet-Fed Mice. And the article contained the following:

Whole-food-based strategies to prevent metabolic diseases are growing interests. Agrocybe cylindracea (AC) is a major edible mushroom with high values of nutrition, but little is known about its health benefits as a portion of whole food. Diet-induced obese, C57BL/6J mice are fed an high-fat diet (HFD) with or without AC (3% or 5%, weight/weight in the diet) for 9 wk. The results show that dietary AC reduced body weight, adipose accumulation, impairment of glucose tolerance, lipid levels, and liver injury in HFD-fed mice. Moreover, AC not only prevents HFD-induced gut disorder, as indicates by the enriched probiotic Bifidobacterium and reduced endotoxin-bearing Proteobacteria, but also improve the lipopolysaccharide (LPS) level and gut tissue structure. Fecal metabolites such as harmine and harmanine are also remarkably altered by AC. Spearman′s correlation anal. reveals that the AC-altered microbes and metabolites are strongly correlated with obesity-related indexes. These findings suggest that dietary AC prevents HFD-induced obesity and its complications in association with modulating gut microbiota and associated fecal metabolites. The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).Reference of 4-(4-Chlorophenyl)piperidin-4-ol

The Article related to agrocybe cylindracea prevent obesity gut microbiota metabolite hfd, agrocybe cylindracea, gut microbiota, high-fat diet, metabolites, whole food, Placeholder for records without volume info and other aspects.Reference of 4-(4-Chlorophenyl)piperidin-4-ol

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

Rampa, Angela; Bartolini, Manuela; Pruccoli, Letizia; Naldi, Marina; Iriepa, Isabel; Moraleda, Ignacio; Belluti, Federica; Gobbi, Silvia; Tarozzi, Andrea; Bisi, Alessandra published an article in 2018, the title of the article was Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer′s disease.Reference of 4-(4-Chlorophenyl)piperidin-4-ol And the article contains the following content:

Alzheimer′s disease still represents an untreated multifaceted pathol., and drugs able to stop or reverse its progression are urgently needed. In this paper, a series of naturally inspired chalcone-based derivatives was designed as structural simplification of our previously reported benzofuran lead compound, aiming at targeting both acetyl (AChE)- and butyryl (BuChE) cholinesterases that, despite having been studied for years, still deserve considerable attention. In addition, the new compounds could also modulate different pathways involved in disease progression, due to the peculiar trans-a,β-unsaturated ketone in the chalcone framework. All mols. presented in this study were evaluated for cholinesterase inhibition on the human enzymes and for antioxidant and neuroprotective activities on a SH-SY5Y cell line. The results proved that almost all the new compounds were low micromolar inhibitors, showing different selectivity depending on the appended substituent; some of them were also effective antioxidant and neuroprotective agents. In particular, compound 4, endowed with dual AChE/BuChE inhibitory activity, was able to decrease ROS formation and increase GSH levels, resulting in enhanced antioxidant endogenous defense. Moreover, this compound also proved to counteract the neurotoxicity elicited by Aβ1-42 oligomers, showing a promising neuroprotective potential. The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).Reference of 4-(4-Chlorophenyl)piperidin-4-ol

The Article related to alzheimer disease chalcone scaffold cholinesterase antioxidant neuroprotective, alzheimer’s disease, antioxidants, chalcones, cholinesterase inhibitors, neuroprotection, Placeholder for records without volume info and other aspects.Reference of 4-(4-Chlorophenyl)piperidin-4-ol

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

On October 31, 2020, Neganova, Margarita E.; Klochkov, Sergey G.; Pukhov, Sergey A.; Afanasieva, Svetlana V.; Aleksandrova, Yulia R.; Yandulova, Ekaterina Y.; Avila-Rodriguez, Marco F.; Mikhaleva, Liudmila M.; Nikolenko, Vladimir N.; Somasundaram, Siva G.; Kirkland, Cecil E.; Aliev, Gjumrakch published an article.Related Products of 39512-49-7 The title of the article was Synthesis and Cytotoxic Activity of Azine Derivatives of 6-Hydroxyxanthanodiene. And the article contained the following:

Background: The conjugates of the sesquiterpene lactone of the eremophilane series of 6-hydroxyxanthanodiene with hydrogenated azines (piperidines and piperazines) have been synthesized and identified by NMR spectrometer. Objective: A lactone with an unusual skeleton “6-hydroxyxanthanodiene” was extracted from the plant Elecampane (Inula helenium L) and identified various species with NMR spectrometer. Methods: The cytotoxic, mitochondrial, and antioxidant activities on different tumor lines such as A549, HCT116, RD and Jurkat were investigated and determined possible mechanisms. Results: The results showed that the most potent compound was IIIi exhibiting highest cytotoxicity against RD cells (IC50 25.23 ± 0.04 μM), depolarized the mitochondrial membrane and was an effective antioxidant (IC50 inhibition of LP 10.68 ± 3.21 μM) without any toxic side effect on healthy cells. Conclusion: The conjugates of sesquiterpene lactone 6-hydroxyxanthanodiene III and hydrogenated azines may help to design potential promising anticancer drugs. The experimental process involved the reaction of 4-(4-Chlorophenyl)piperidin-4-ol(cas: 39512-49-7).Related Products of 39512-49-7

The Article related to hydroxyxanthanodiene azine derivative cytotoxicity anticancer drug, 6-hydroxyxanthanodiene, anticancer drug, antioxidants, apoptosis, azines, cytotoxicity, mitochondria, Placeholder for records without volume info and other aspects.Related Products of 39512-49-7

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem